Works by Oliva, Esther Natalie

Results: 24
    1
    2
    3

    Real‐world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 4, p. 1246, doi. 10.1111/bjh.20025
    By:
    • Metafuni, Elisabetta;
    • Brioschi, Filippo Achille;
    • Patriarca, Andrea;
    • Leoni, Claudia;
    • Battipaglia, Giorgia;
    • Carlino, Daniela;
    • Condorelli, Annalisa;
    • Di Giacomo, Valeria;
    • Marktel, Sarah;
    • Marzilli, Maria Antonietta;
    • Miglino, Maurizio;
    • Oliva, Esther Natalie;
    • Sau, Antonella;
    • Ricco, Alessandra;
    • Sanpaolo, Grazia;
    • Trolese, Annarita;
    • Iori, Anna Paola;
    • Sica, Simona;
    • Barcellini, Wilma;
    • Fattizzo, Bruno
    Publication type:
    Article
    4

    Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 2049, doi. 10.1111/bjh.19316
    By:
    • Sarocchi, Matteo;
    • Li, Junmin;
    • Li, Xiao;
    • Wu, Depei;
    • Montaño Figueroa, Efreen;
    • Rodriguez, Maria Guadalupe;
    • Hou, Ming;
    • Finelli, Carlo;
    • Shi, Hong‐Xia;
    • Xiao, Zhijian;
    • Oliva, Esther Natalie;
    • Gercheva Kyuchukova, Liana;
    • Drummond, Mark;
    • Symeonidis, Argiris;
    • Velazquez, Eric J.;
    • Rivoli, Giulia;
    • Izquierdo, Miguel;
    • Kolekar, Yogita;
    • Spallarossa, Paolo;
    • Angelucci, Emanuele
    Publication type:
    Article
    5
    6
    7

    Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 3, p. e131, doi. 10.1016/j.clml.2024.10.007
    By:
    • Poloni, Antonella;
    • Raaschou-Jensen, Klas;
    • Mohedo, Francisca Hernandez;
    • Paolini, Stefania;
    • Oliva, Esther Natalie;
    • Buccisano, Francesco;
    • Vasconcelos, Alberto;
    • Kim, Iris;
    • Makwana, Aidan;
    • Bernasconi, David;
    • Rosettani, Barbara;
    • Prebet, Thomas;
    • Santini, Valeria
    Publication type:
    Article
    8
    9
    10
    11
    12

    Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE).

    Published in:
    Cancers, 2023, v. 15, n. 9, p. 2441, doi. 10.3390/cancers15092441
    By:
    • Oliva, Esther Natalie;
    • Candoni, Anna;
    • Salutari, Prassede;
    • Palumbo, Giuseppe A.;
    • Reda, Gianluigi;
    • Iannì, Giuseppe;
    • Tripepi, Giovanni;
    • Cuzzola, Maria;
    • Capelli, Debora;
    • Mammì, Corrado;
    • Alati, Caterina;
    • Cannatà, Maria Concetta;
    • Niscola, Pasquale;
    • Serio, Bianca;
    • Musto, Pellegrino;
    • Vigna, Ernesto;
    • Volpe, Antonio;
    • Melillo, Lorella Maria Antonia;
    • Arcadi, Maria Teresa;
    • Mannina, Donato
    Publication type:
    Article
    13
    14
    15
    16
    17

    Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 27, doi. 10.3390/jcm11010027
    By:
    • Oliva, Esther Natalie;
    • Platzbecker, Uwe;
    • Garcia-Manero, Guillermo;
    • Mufti, Ghulam J.;
    • Santini, Valeria;
    • Sekeres, Mikkael A.;
    • Komrokji, Rami S.;
    • Shetty, Jeevan K.;
    • Tang, Derek;
    • Guo, Shien;
    • Liao, Weiqin;
    • Zhang, George;
    • Ha, Xianwei;
    • Ito, Rodrigo;
    • Lord-Bessen, Jennifer;
    • Backstrom, Jay T.;
    • Fenaux, Pierre
    Publication type:
    Article
    18

    Health‐related quality of life in patients with β‐thalassemia: Data from the phase 3 BELIEVE trial of luspatercept.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 1, p. 113, doi. 10.1111/ejh.13975
    By:
    • Cappellini, Maria Domenica;
    • Taher, Ali T.;
    • Piga, Antonio;
    • Shah, Farrukh;
    • Voskaridou, Ersi;
    • Viprakasit, Vip;
    • Porter, John B.;
    • Hermine, Olivier;
    • Neufeld, Ellis J.;
    • Thompson, Alexis A.;
    • Tang, Derek;
    • Yucel, Aylin;
    • Lord‐Bessen, Jennifer;
    • Yu, Peiwen;
    • Guo, Shien;
    • Shetty, Jeevan K.;
    • Miteva, Dimana;
    • Zinger, Tatiana;
    • Backstrom, Jay T.;
    • Oliva, Esther Natalie
    Publication type:
    Article
    19
    20

    Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2).

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 21, p. 11646, doi. 10.3390/ijms252111646
    By:
    • Oliva, Esther Natalie;
    • Cuzzola, Maria;
    • Porta, Matteo Della;
    • Candoni, Anna;
    • Salutari, Prassede;
    • Palumbo, Giuseppe A.;
    • Reda, Gianluigi;
    • Iannì, Giuseppe;
    • Zampini, Matteo;
    • D'Amico, Saverio;
    • Tripepi, Giovanni;
    • Capelli, Debora;
    • Alati, Caterina;
    • Cannatà, Maria Concetta;
    • Niscola, Pasquale;
    • Serio, Bianca;
    • Barillà, Santina;
    • Musto, Pellegrino;
    • Vigna, Ernesto;
    • Melillo, Lorella Maria Antonia
    Publication type:
    Article
    21

    Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 8, p. E204, doi. 10.1002/ajh.26960
    By:
    • Lanino, Luca;
    • Restuccia, Francesco;
    • Perego, Alessandra;
    • Ubezio, Marta;
    • Fattizzo, Bruno;
    • Riva, Marta;
    • Consagra, Angela;
    • Musto, Pellegrino;
    • Cilloni, Daniela;
    • Oliva, Esther Natalie;
    • Palmieri, Raffaele;
    • Poloni, Antonella;
    • Califano, Catello;
    • Capodanno, Isabella;
    • Itri, Federico;
    • Elena, Chiara;
    • Fozza, Claudio;
    • Pane, Fabrizio;
    • Pelizzari, Anna Maria;
    • Breccia, Massimo
    Publication type:
    Article
    22

    ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1037, doi. 10.1002/ajh.24842
    By:
    • Buckstein, Rena;
    • Balleari, Enrico;
    • Wells, Richard;
    • Santini, Valeria;
    • Sanna, Alessandro;
    • Salvetti, Chiara;
    • Crisà, Elena;
    • Allione, Bernardino;
    • Danise, Paolo;
    • Finelli, Carlo;
    • Clavio, Marino;
    • Poloni, Antonella;
    • Salvi, Flavia;
    • Cilloni, Daniela;
    • Oliva, Esther Natalie;
    • Musto, Pellegrino;
    • Houston, Brett;
    • Zhu, Nancy;
    • Geddes, Michelle;
    • Leitch, Heather
    Publication type:
    Article
    23

    Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study.

    Published in:
    2025
    By:
    • Sekeres, Mikkael A.;
    • Santini, Valeria;
    • Díez-Campelo, Maria;
    • Komrokji, Rami S.;
    • Fenaux, Pierre;
    • Savona, Michael R.;
    • Madanat, Yazan F.;
    • Valcárcel-Ferreiras, David;
    • Oliva, Esther Natalie;
    • Regnault, Antoine;
    • Creel, Kristin;
    • Sengupta, Nishan;
    • Dougherty, Souria;
    • Shah, Sheetal;
    • Sun, Libo;
    • Wan, Ying;
    • Navada, Shyamala;
    • Zeidan, Amer M.;
    • Platzbecker, Uwe
    Publication type:
    Letter to the Editor
    24